<abstract xmlns="http://www.w3.org/1999/xhtml"><p> This article aims at analysing the financial balance within the global pharmaceutical industry, starting from the assumption that „In the pharmaceutical industry there is sufficient liquidity to cover payment obligations”. The analysed companies are part of the exclusive group comprising the top 20 global companies, e.g. GlaxoSmithKline, Merck &amp; Co., Sanofi-Aventis and Bayer. The research conducted is based on an analysis over time of the relationship between floating assets, floating assets requirement and net cash from 2006 to 2013, and highlights the main developments of the indicators before the onset of the financial and economic crisis and after its outbreak.</p></abstract>

This article aims at analysing the financial balance within the global pharmaceutical industry, starting from the assumption that „In the pharmaceutical industry there is sufficient liquidity to cover payment obligations”. The analysed companies are part of the exclusive group comprising the top 20 global companies, e.g. GlaxoSmithKline, Merck & Co., Sanofi-Aventis and Bayer. The research conducted is based on an analysis over time of the relationship between floating assets, floating assets requirement and net cash from 2006 to 2013, and highlights the main developments of the indicators before the onset of the financial and economic crisis and after its outbreak.

Study Regarding the Evolution of the Financial Balance in the Pharmaceutical Industry

Lucian Blaga University of Sibiu, Romania

Studies in Business and Economics

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

This article aims at analysing the financial balance within the global pharmaceutical industry, starting from the assumption that „In the pharmaceutical...

Study Regarding the Evolution of the Financial Balance in the Pharmaceutical Industry

Data publikacji: 02 mar 2016

Zakres stron: 137 - 146

DOI: https://doi.org/10.1515/sbe-2015-0044

Słowa kluczowe
pharmaceutical industry, liquidity, floating assets, floating assets requirement, net cash

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Study Regarding the Evolution of the Financial Balance in the Pharmaceutical Industry

Data publikacji: 02 mar 2016

Zakres stron: 137 - 146

DOI: https://doi.org/10.1515/sbe-2015-0044

Słowa kluczowepharmaceutical industry, liquidity, floating assets, floating assets requirement, net cash

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Słowa kluczowe
pharmaceutical industry, liquidity, floating assets, floating assets requirement, net cash